Association Between Sudden Sensorineural Hearing Loss and History of Statin Use: A Nested Case-Control Study. (July 2021)

• Record Type: Journal Article
• Authors: Kim, So Young; Wee, Jee Hye; Min, Chanyang; Yoo, Dae Myoung; Choi, Hyo Geun
• Is Part Of: Otolaryngology--head and neck surgery. Volume 165:Number 1(2021)
• Page Start: 149
• Page End: 156
• Publication Date: 2021-07
• Subjects: hearing loss -- sudden -- hydroxymethylglutaryl-CoA reductase inhibitors -- cohort studies -- case-control studies; Head -- Surgery -- Periodicals; Neck -- Surgery -- Periodicals; Otolaryngology -- Periodicals; 617.51
• DOI: 10.1177/0194599820969630
• Languages: English
• ISSNs: 0194-5998

Abstract

Objective: The effect of statin on sudden sensorineural hearing loss (SSNHL) remains unclear. Thus, this study aimed to investigate the association between prior statin use and SSNHL. Study Design: A nested case-control study. Setting: Participants aged ≥40 years were enrolled from the 2002-2015 Korean National Health Insurance Service–Health Screening Cohort. Methods: A total of 5876 patients with SSNHL were matched with 23, 504 control participants for age, sex, income, and region of residence. History of statin use for 2 years before SSNHL onset was investigated between the groups. The odds ratios (ORs) of the length of statin use for SSNHL stratified by age, sex, income, and region of residence were analyzed with conditional logistic regression. Dyslipidemia, total cholesterol, blood pressure, blood glucose, hemoglobin, obesity, smoking, alcohol consumption, and Charlson Comorbidity Index score were adjusted. The adjusted variables were subjected to subgroup analyses. Results: The SSNHL group had a longer duration of statin use than the control group (mean [SD], 81.9 [197.7] days vs 72.7 [188.0] days; P = .001). However, statin use was not associated with SSNHL after adjusting for the confounders (adjusted OR, 1.04; 95% CI, 0.98-1.11; P = .245). There was a positive correlation between statin use and SSNHL in the crude model (crude OR, 1.10; 95% CI, 1.04-1.16; P = .001). However, there was no association between statin use and SSNHL in all subgroup analyses. Conclusion: Previous statin use was not associated with SSNHL.